Financhill
Back

CRISPR Therapeutics AG Quote, Financials, Valuation and Earnings

Buy
63

CRSP
CRISPR Therapeutics AG

Last Price:
55.25
Seasonality Move:
9.74%

7 Day Trial

ALL ACCESS PASS

$ 7

CRISPR Therapeutics AG Price Quote

$55.25
+0.01 (+-0.86%)
(Updated: May 25, 2024 at 6:11 AM ET)

CRISPR Therapeutics AG Key Stats

Buy
63
CRISPR Therapeutics AG (CRSP) is a Buy

Day range:
$55.03 - $56.29
52-week range:
$37.55 - $91.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.25%

Volume:
618.2K
Avg. volume:
1.4M
1-year change:
-16.15%
Market cap:
$4.7B
Revenue:
$370M
EPS:
$-2.69

How Much Does CRISPR Therapeutics AG Make?

Data Unavailable

Is CRISPR Therapeutics AG Growing As A Company?

Data Unavailable

CRISPR Therapeutics AG Stock Price Performance

What Is CRISPR Therapeutics AG 52-Week High & Low?

CRISPR Therapeutics AG Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CRISPR Therapeutics AG?

Is CRISPR Therapeutics AG Cash Flow Positive?

  • What Is CRSP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$159.4M
  • What Is CRISPR Therapeutics AG’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $363.2M
  • What Is CRISPR Therapeutics AG’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $159M

CRISPR Therapeutics AG Return On Invested Capital

Data Unavailable

CRISPR Therapeutics AG Earnings Date & Stock Price

CRISPR Therapeutics AG Competitors

CRISPR Therapeutics AG Dividend Yield

Data Unavailable

CRISPR Therapeutics AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 2.55%
Revenue: 0% -98.13%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 11
Sell Recommendations: 2
Price Target: 86.57
Upside from Last Price: 56.71%

Major Shareholders

  • How many CRSP shares are owned by institutional investors?
    94.2M CRSP shares are owned by institutional investors
  • How many CRSP shares are owned by insiders?
    1.6M CRSP shares are owned by insiders